NEW YORK, May 07, 2018 -- Safirstein Metcalf LLP and HGT Law remind investors that a shareholder “opt-out” lawsuit (“Lawsuit”) has been filed on behalf of a group of retail investors (“Investors”) against Valeant Pharmaceuticals International, Inc. (“Valeant”) and its senior officers for violations of federal securities laws and invite investors to contact the firms.
Previously, on June 24, 2016, a class action complaint was filed in the U.S. District Court for the District of New Jersey, on behalf of a class consisting of all purchasers of the common stock of Valeant (“Class Action”). More than twenty lawsuits have been filed on behalf of institutional investors who have decided to opt out of the Class Action to directly pursue their own claims. To date, the Lawsuit commenced by Safirstein Metcalf LLP and HGT Law is the only opt-out lawsuit that has been filed on behalf of retail investors.
A copy of the complaint filed by Safirstein Metcalf LLP and HGT Law on behalf of the Investors can be found here. For more information on opt-out lawsuits, see our publication here.
If you purchased Valeant common stock during the period from January 4, 2013 through March 15, 2016 and suffered losses of more than $200,000, then you may wish to consider opting out of the existing class action and joining the Lawsuit. A number of large institutional investors such as T. Rowe Price, Blackrock and Prudential Insurance Company have already opted out of the class action. If you would like to learn about the options available to you, please call 1-800-221-0015, email [email protected] or visit www.valeantshareholderlitigation.com
Company: Valeant Pharmaceuticals International, Inc.
Exchange: NYSE
Ticker: VRX
Class Period: 01/04/2013 – 03/15/2016
About Safirstein Metcalf LLP and HGT Law
Safirstein Metcalf LLP focuses its practice on shareholder rights. The law firm also practices in the areas of antitrust and consumer protection. All of the Firm’s legal endeavors are rooted in its core mission: provide investor and consumer protection.
HGT Law is a boutique commercial litigation firm based in New York. The firm focuses on representing investors in securities litigation and corporate governance/derivative litigation.
Attorney advertising. Prior results do not guarantee a similar outcome.
Safirstein Metcalf LLP
Peter Safirstein, Esq.
Safirstein Metcalf LLP
The Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118


Samsung Surpasses $1 Trillion Market Cap Amid AI Chip Boom and Apple Partnership Talks
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy
Hugo Boss Beats Q1 Profit Expectations Despite Market Headwinds
Meta Plans $13B AI Data Center Financing in Texas Amid Surging Big Tech Investment
Agentic AI Boom to Drive Massive Growth in CPU Market, UBS Says
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations
BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles
Regis Resources and Vault Minerals to Merge in $10.7B Gold Deal
BHP Attracts AI-Focused Investors as Copper Demand Surges
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move 



